Therapy News and Research

RSS

Stanford researchers show how to prevent immune response to gene therapy in mouse model

Stanford University School of Medicine researchers have demonstrated that gene therapy can be effective without causing a dangerous side effect common to all gene therapy: an autoimmune reaction to the normal protein, which the patient's immune system is encountering for the first time.

4 Sep 2018

Novel method using big data tools shows promising routes for research

A group of researchers affiliated to the University of São Paulo - campus Ribeirão Preto, Brazil, used big data tools such as data mining and network analysis to develop a method to help scientists and companies identify technological routes, trends and partnerships in any knowledge area. For this purpose, it collected information from patent databases around the world.

3 Sep 2018

Finding which chemotherapy regimen is associated with best outcomes for patients with bladder cancer

Patients with muscle-invasive bladder cancer have been shown to benefit from chemotherapy prior to surgical removal of the bladder.

31 Aug 2018

Intervention to reduce supine sleep during pregnancy may provide maternal, fetal health benefits

A new study suggests that an intervention to reduce supine sleep in late pregnancy may promote maternal and fetal health.

31 Aug 2018

Modified Nurr1 protein may pave way for new Parkinson's therapy

Researchers have modified the protein Nurr1 so that it can enter cells from the outside. Nurr1 deficiency may be one of the causes of Parkinson's disease.

31 Aug 2018

Groundbreaking CURATE.AI platform halts progression of advanced cancer

A translational research team led by the National University of Singapore has harnessed CURATE.AI, a powerful artificial intelligence platform, to successfully treat a patient with advanced cancer, completely halting disease progression.

31 Aug 2018

Brain exhibits similar changes in both ADHD and emotional instability disorders

In both ADHD and emotional instability disorders (eg borderline and antisocial personality disorder as well as conduct disorder in children), the brain exhibits similar changes in overlapping areas, meaning that the two types of conditions should be seen as related and attention should be paid to both during diagnosis.

31 Aug 2018

New Euro-GASP program monitors continued effectiveness of treatment regimen for gonorrhea

Neisseria gonorrhoea continues to show high levels of resistance to azithromycin across the European Union and European Economic Area, according to the 2016 results of the European Gonococcal Antimicrobial Surveillance Programme.

31 Aug 2018

NUS researchers harness AI platform to treat patient with advanced cancer

31 Aug 2018

Simple intervention increases use of HIV medications in injection-drug users

A relatively simple effort to provide counseling and connect injection-drug users with resources could prove powerful against the spread of HIV in a notoriously hard-to-reach population, new research suggests.

31 Aug 2018

Subcutaneous injection of new protein helps treat hemophilia more effectively

Patients with hemophilia bleed spontaneously or following trauma. The most common sites of bleeding are into joints, but bleeds can also happen into any tissue in the body including the muscles, brain, or eyes.

31 Aug 2018

Single dose of cannabidiol showed effective results in rats with symptoms of depression

Commercial antidepressants typically take two to four weeks to have a significant effect on a depressed patient. They are also inneffective in approximately 40% of the cases.

31 Aug 2018

OSA patients have higher risk of developing gout, research reveals

New research reveals that people with obstructive sleep apnea (OSA) have a higher risk of developing gout, even beyond the first years after being diagnosed with the sleep disorder. The findings are published in Arthritis & Rheumatology, an official journal of the American College of Rheumatology.

30 Aug 2018

Pfizer terminates clinical studies evaluating domagrozumab for treatment of Duchenne muscular dystrophy

Pfizer Inc. announced today that it is terminating two ongoing clinical studies evaluating domagrozumab (PF-06252616) for the treatment of Duchenne muscular dystrophy (DMD): a Phase 2 safety and efficacy study (B5161002) and an open-label extension study (B5161004).

30 Aug 2018

Shionogi launches Mulpleta in the U.S for safe, effective treatment of thrombocytopenia

Shionogi & Co., Ltd. announced today that Mulpleta (lusutrombopag), a once-daily, orally administered, small molecule thrombopoietin (TPO) receptor agonist for the treatment of thrombocytopenia in adult patients with chronic liver disease (CLD) who are scheduled to undergo a procedure, is now available throughout the United States.

30 Aug 2018

Therapy News and Research

Stanford researchers show how to prevent immune response to gene therapy in mouse model

Novel method using big data tools shows promising routes for research

Finding which chemotherapy regimen is associated with best outcomes for patients with bladder cancer

Intervention to reduce supine sleep during pregnancy may provide maternal, fetal health benefits

Modified Nurr1 protein may pave way for new Parkinson's therapy

Groundbreaking CURATE.AI platform halts progression of advanced cancer

Brain exhibits similar changes in both ADHD and emotional instability disorders

New Euro-GASP program monitors continued effectiveness of treatment regimen for gonorrhea

NUS researchers harness AI platform to treat patient with advanced cancer

Simple intervention increases use of HIV medications in injection-drug users

Subcutaneous injection of new protein helps treat hemophilia more effectively

Single dose of cannabidiol showed effective results in rats with symptoms of depression

OSA patients have higher risk of developing gout, research reveals

Pfizer terminates clinical studies evaluating domagrozumab for treatment of Duchenne muscular dystrophy

Shionogi launches Mulpleta in the U.S for safe, effective treatment of thrombocytopenia

HKBU chemists discover metal-based inhibitor to treat triple-negative breast cancer

Philips announces inclusion of iFR into ESC’s updated revascularization guidelines

Ultralaser treatment reduces pain in patients with fibromyalgia

New model could predict personalized waiting time for progression in colorectal cancer

Scientists explore DNA replication errors that can lead to cancer

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News